Novartis shares down as failed cholesterol drug study increases pipeline pressure

HHimma Investments

NVDA 218.42 −3.2%TSLA 366.23 −0.5%AAPL 323.02 +2.4%GOOGL 330.6 −2.3%AMZN 252.46 +0.0%HOOD 115 −2.0%ENAUSD 0.180179MORPHOUSD 2.63ONDOUSD 0.375057 −0.6%PUMPUSD 0.0042852 +0.2%WLDUSD 0.489115 +19.1%TXGE 8388.76953 −1.7%MU 986 −1.4%SNDK 1701.195 −2.1%AVGO 364.15 −1.2%SPCX 150 −2.3%MSFT 491.55 −0.5%META 657.6 +7.2%DELL 520.5 −2.5%INTC 101.94 −2.4%AMD 509.18 −2.3%PLTR 167.7 −1.5%GOOG 328.095 −2.2%MRVL 232.1 +3.0%ORCL 158.35 −2.6%TSM 431.945 −1.6%LITE 971.255 −0.7%CRM 244.96 −1.7%BE 266.56 −1.0%MSTR 130.915 −4.1%SNOW 333 −0.7%NBIS 230.7 −5.4%AMAT 458.525 −2.2%SKHY 190.8 +2.8%PANW 341.87 +1.5%LLY 1127.57 +0.3%STX 876.97 −3.0%CRDO 164.49 −1.9%WDC 468.35 −1.9%WMT 106.09 +0.0%MRNA 133.37 −5.0%CRWD 212.35 +2.2%LRCX 304.44 −5.0%NFLX 75.715 −1.4%HPE 56.36 +0.6%CRWV 90.53430176 −9.3%NOW 133.26 −0.7%WBS 77.57 0.0%XOM 163.895 +2.0%ASML 1712.23 −3.0%09/10/2026, 11:06 ET · STALE · coingecko,twelve_data,twelve_data_websocket

FILTERS · MARKET · ALL SCORES

COVERAGE

My names Portfolio only Market-wide

MIN SCORE

All ≥5 ≥7 ≥9